Walpar Nutritions
Walpar Nutritions Share Price Chart
Walpar Nutritions last traded at ₹26.10 (2026-10-13). Over the past month the stock moved +13.5%, three months the stock moved -20.9%, year the stock moved -33.5%. Its closing range over 52 weeks is ₹22.00 – ₹48.30, with the latest close 46.0% below the high.
Closing prices up to 2026-10-13.
About Walpar Nutritions
Incorporated in 2009, Walpar Nutrition Ltd develops and manufactures various pharmaceutical products.[1]
Business Overview:[1][2] WNL is in the business of manufacturing and trading of Pharmaceutical, Nutraceutical, Herbal, and Ayurvedic Products. The company has a presence across 42+ countries and has served 650+ clients.
Fundamentals
Quarterly Results
In the latest quarter (Mar 2026), Walpar Nutritions reported sales of ₹42.30 crore (+34.8%) and net profit of ₹1.50 crore (+16.3%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 42.30 | 3.72 | 8.79 | 1.50 | 1.26 |
| Sep 2025 | 36.49 | 2.94 | 8.06 | 1.50 | 1.37 |
| Mar 2025 | 39.24 | 3.08 | 7.85 | 1.39 | 1.11 |
| Sep 2024 | 32.53 | 2.64 | 8.12 | 1.41 | 1.37 |
| Mar 2024 | 31.38 | 2.76 | 8.80 | 1.29 | 1.26 |
| Sep 2023 | 31.14 | 1.99 | 6.39 | 0.65 | 0.43 |
| Mar 2023 | 18.62 | 2.50 | 13.43 | 1.14 | 1.07 |
| Sep 2022 | 16.52 | 1.00 | 6.05 | -0.33 | -0.42 |
| Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales growth | +33.2% | +122.7% | +145.5% | +96.9% | +110.7% | +17.2% | +34.8% |
| Operating profit growth | +390.2% | +290.2% | +441.2% | +164.0% | +23.2% | +47.7% | +34.8% |
| Net profit growth | +850.0% | +441.7% | +437.5% | – | +21.9% | +130.8% | +16.3% |
| EPS growth | +463.2% | +207.1% | +366.7% | – | +3.7% | +218.6% | +0.0% |
| OPM % | 13.4% | 6.4% | 8.8% | 8.1% | 7.9% | 8.1% | 8.8% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Walpar Nutritions reported sales of ₹78.79 crore (+9.8%) and net profit of ₹3.00 crore (+7.5%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 78.79 | 6.66 | 8.45 | 3.00 | 2.63 |
| Mar 2025 | 71.76 | 5.72 | 7.97 | 2.79 | 2.47 |
| Mar 2024 | 62.52 | 4.75 | 7.60 | 1.94 | 1.68 |
| Mar 2023 | 35.14 | 3.49 | 9.93 | 0.81 | 0.65 |
| Mar 2022 | 26.76 | 1.02 | 3.81 | 0.36 | 0.42 |
| Mar 2021 | 6.07 | 0.46 | 7.58 | 0.15 | 0.22 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales growth | +340.9% | +31.3% | +77.9% | +14.8% | +9.8% |
| Operating profit growth | +121.7% | +242.2% | +36.1% | +20.4% | +16.4% |
| Net profit growth | +140.0% | +125.0% | +139.5% | +43.8% | +7.5% |
| EPS growth | +90.9% | +54.8% | +158.5% | +47.0% | +6.5% |
| OPM % | 3.8% | 9.9% | 7.6% | 8.0% | 8.5% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Walpar Nutritions.
Get Free AI Stock Analysis FREE →Latest News
No recent news available for Walpar Nutritions.
Frequently Asked Questions
What is the share price of Walpar Nutritions today?
Walpar Nutritions shares were last quoted at ₹26.10 (+0.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Walpar Nutritions?
Walpar Nutritions has a price-to-earnings (P/E) ratio of 8.03 and a price-to-book (P/B) ratio of 1.36. The industry P/E is 53.33.
What is the 52-week high and low of Walpar Nutritions?
The 52-week high of Walpar Nutritions is ₹50.60 and the 52-week low is ₹21.25.
What is the market cap of Walpar Nutritions?
The market capitalisation of Walpar Nutritions is about ₹25.78 crore.
How did Walpar Nutritions perform in its latest quarterly results?
In the latest quarter (Mar 2026), Walpar Nutritions reported sales of ₹42.30 crore (+34.8%) and net profit of ₹1.50 crore (+16.3%), compared with the same quarter last year.
Is Walpar Nutritions a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Walpar Nutritions has a 3-year ROE of 14.00%, 3-year profit growth of 61.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Walpar Nutritions?
Promoters hold about 68.82% of Walpar Nutritions.
Which sector does Walpar Nutritions belong to?
Walpar Nutritions belongs to the Pharmaceuticals & Drugs sector.